Evidence map›Paper›PMID 15823539›Full record

ArticleCurrent biology : CB2005

Inhibition of a yeast LTR retrotransposon by human APOBEC3 cytidine deaminases.

James A Dutko, Alexandra Schäfer, Alison E Kenny, Bryan R Cullen, M Joan Curcio

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Current biology : CB, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed
7.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 138 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

James A DutkoLaboratory of Developmental Genetics, Wadsworth Center and Department of Biomedical Sciences, University at Albany, P.O. Box 22002, Albany, New York 12201, USA.
Alexandra Schäfer
Alison E Kenny
Bryan R Cullen
M Joan Curcio
Wadsworth Center · USDuke Medical Center · US

Funding

REGULATION OF RETROTRANSPOSITION IN S. CEREVISIAER01GM052072 · NIGMS · WADSWORTH CENTER · PI CURCIO, M JOAN · 2000 to 2013
$3.3M
Molecular Mechanism of HIV-1 Vif FunctionR01AI057099 · NIAID · DUKE UNIVERSITY · PI CULLEN, BRYAN R. · 2004 to 2007
$1.4M
REGULATION OF RETROTRANSPOSITION IN S CEREVISIAER29GM052072 · NIGMS · WADSWORTH CENTER · PI CURCIO, M JOAN · 1995 to 1999
–
NIAID NIH HHS AI57099NIAID NIH HHS R01 AI057099NIGMS NIH HHS GM52072NIGMS NIH HHS R01 GM052072NIGMS NIH HHS R29 GM052072
6 · The paper itself

Abstract

The mammalian APOBEC3 family of cytidine deaminases includes several members that possess potent antiretroviral activity. Human APOBEC3F and APOBEC3G are specifically incorporated into human immunodeficiency virus type 1 (HIV-1) progeny virions in the absence of virion infectivity factor (Vif), where they deaminate deoxycytidine to deoxyuridine on the minus strand of nascent reverse transcripts. Editing of the HIV-1 cDNA leads to its degradation or to G to A hypermutation of the integrated provirus. Here, we show that APOBEC3 proteins also restrict the activity of a distantly related long terminal repeat (LTR) retrotransposon. When expressed in the yeast Saccharomyces cerevisiae, human APOBEC3C, APOBEC3F, or APOBEC3G or mouse APOBEC3 potently inhibit replication of the Ty1 LTR retrotransposon. APOBEC3G interacts with Ty1 Gag and is packaged into Ty1 virus-like particles (VLPs) by a mechanism that closely resembles the one it uses to enter HIV-1 virions. Expression of APOBEC3G results in a reduced level of Ty1 cDNA integration and G to A editing of integrated Ty1 cDNA. Our findings indicate that APOBEC3G restricts Ty1 and HIV-1 by similar mechanisms and suggest that the APOBEC3 proteins target a substantially broader spectrum of retroelements than previously appreciated.

Indexed as

AnimalsAPOBEC-3G DeaminaseBlotting, WesternCells, CulturedCytidine DeaminaseDNA, ComplementaryDNA PrimersDNA ReplicationGenes, polGlutathione TransferaseHIV-1HumansMiceMultigene FamilyNucleoside DeaminasesPlasmidsAPOBEC-3G DeaminaseAPOBEC3G protein, humanCytidine DeaminaseDNA, ComplementaryDNA PrimersGlutathione TransferaseNucleoside DeaminasesProteinsRepressor ProteinsRetroelements

Identifiers

PMID15823539
PMCPMC2839876
OpenAlexW2074247685

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.